This bulletin was published on 3 June
The Pharmaceutical Supply Chain Initiative (PSCI) Marking a year of global impact

The Pharmaceutical Supply Chain Initiative (PSCI) Marking a year of global impact

  • Building on more than a decade of collaboration, the PSCI celebrates continued growth in membership, record audit sharing, and sector-wide engagement to strengthen responsible practices across the pharmaceutical and healthcare value chain.

  • The PSCI continues to serve as one voice for the pharmaceutical and healthcare industry, defining, instilling, and driving responsible value chain practices through collaboration, shared tools, and sector-wide engagement.

3 June 2025 –The Pharmaceutical Supply Chain Initiative (PSCI) has released its 2024 Annual Report, celebrating a year of strategic transformation and measurable progress in building responsible supply chains across the pharmaceutical and healthcare sectors.

Now representing over 70% of the industry by revenue, PSCI’s 81 member companies continue to collaborate through a shared commitment to the PSCI Principles for Responsible Supply Chain Management. In 2024, PSCI launched a new three-year strategy focused on deepening impact through its three core workstreams: Audit, Capability Building, and Projects.

Reflecting on the previous year, the 2024 PSCI Annual Report showcases the sector’s progress through the PSCI and its three modes of impact:

More Info…